16 Rivaroxaban (Xarelto): Rivaroxaban is indicated for the treatment of DVT and PE plus reduction in risk of recurrence of DVT and/or PE in patients at risk for recurrent DVT and/or PE after completion of initial treatment lasting at least 6 months
Glutathione works by inhibiting tyrosinase, an enzyme responsible for melanin production
However, when combined with other medications that can induce hypoglycemia (especially insulin or sulfonylureas), the risk of low blood sugar increases
Electrolyte replacement becomes essential during active diarrhea
Additional data show that liraglutide reduces several markers of cardiovascular risk, such as body weight, A1C levels, Systolic BP, C-reactive protein, type 2 natriuretic peptide, and PAI-1 [108, 109]